文献速递老年综合评估老年慢病共病管理

基于理赔数据的疾病严重程度标记能否提升多病共存指数的预测能力?

Can markers of disease severity improve the predictive power of claims-based multimorbidity indices?
PubMed 文献 · J Am Geriatr Soc · 2022-12-10

该研究基于Medicare理赔数据与健康与退休研究(HRS)链接数据,开发了7个可应用于多种疾病的二分类疾病严重程度标记,并在5012名受试者中检验其能否提升理赔数据多病共存指数对ADL下降、IADL下降、住院和死亡的预测能力。结果显示,对多数疾病而言,加入严重程度标记后c统计量提升极小(≤0.002),多病指数中加入最有希望的标记后c统计量提升也仅为<0.001-0.007。结论认为基于理赔数据的疾病严重程度标记未能实质性改善多病共存指数的预测能力。

要点

  • 7个基于理赔数据的疾病严重程度标记对多数疾病预测ADL下降和死亡的c统计量提升≤0.002。
  • 多病指数中加入最有希望的严重程度标记后,预测四个结局的c统计量提升<0.001-0.007。
  • 仅少数个别疾病的预测能力因加入严重程度标记而有较明显提升。

核心结论

  • 基于理赔数据的疾病严重程度标记未能实质性提升多病共存指数对ADL下降、死亡及其他重要结局的预测能力。

研究设计与样本

  • 研究开发了7个二分类疾病严重程度标记,基于疾病相关门诊就诊次数、急诊就诊次数、住院次数、是否就诊于通常治疗该疾病的专科医生以及ICD-9编码所提示的疾病进展或症状表现。
  • 使用Medicare理赔数据与健康与退休研究(HRS)链接数据,共纳入5012名受试者,中位年龄76岁,58%为女性。
  • 比较纳入严重程度标记的模型与仅纳入疾病有无的等效模型对ADL下降、IADL下降、住院和死亡的预测能力。

主要发现

  • 对多数单独检验的疾病,加入7个严重程度标记中的每一个后,预测ADL下降和死亡的c统计量提升极小(≤0.002)。
  • 对少数个别疾病,加入严重程度标记后预测能力有较明显提升。
  • 在多病多病共存指数中加入最有希望的标记后,预测ADL下降、IADL下降、住院和死亡的c统计量提升为<0.001-0.007。

临床怎么用

  • 在利用理赔数据评估老年多病共存负担时,不宜期望通过简单加入疾病严重程度标记来实质性改善对ADL下降、死亡等结局的预测。
  • 对于少数特定疾病,可考虑进一步探索严重程度标记的预测价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Claims-based measures of multimorbidity, which evaluate the presence of a defined list of diseases, are limited in their ability to predict future outcomes. We evaluated whether claims-based markers of disease severity could improve assessments of multimorbid burden. METHODS: We developed 7 dichotomous markers of disease severity which could be applied to a range of diseases using claims data. These markers were based on the number of disease-associated outpatient visits, emergency department visits, and hospitalizations made by an individual over a defined interval; whether an individual with a given disease had outpatient visits to a specialist who typically treats that disease; and ICD-9 codes which connote more versus less advanced or symptomatic manifestations of a disease. Using Medicare claims linked with Health and Retirement Study data, we tested whether including these markers improved ability to predict ADL decline, IADL decline, hospitalization, and death compared to equivalent models which only included the presence or absence of diseases. RESULTS: Of 5012 subjects, median age was 76 years and 58% were female. For a majority of diseases tested individually, adding each of the 7 severity markers yielded minimal increase in c-statistic (≤0.002) for outcomes of ADL decline and mortality compared to models considering only the presence versus absence of disease. Gains in predictive power were more substantial for a small number of individual diseases. Inclusion of the most promising marker in multi-disease multimorbidity indices yielded minimal gains in c-statistics (<0.001-0.007) for predicting ADL decline, IADL decline, hospitalization, and death compared to indices without these markers. CONCLUSIONS: Claims-based markers of disease severity did not contribute meaningfully to the ability of multimorbidity indices to predict ADL decline, mortality, and other important outcomes.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Rizzo A, Jing B, Boscardin WJ, et al. Can markers of disease severity improve the predictive power of claims-based multimorbidity indices? J Am Geriatr Soc. 2022. PMID: 36495264. doi:10.1111/jgs.18150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。